Xanthoma is a dermatology condition characterized by fatty growth underneath the skin. The growth can vary in size ranging from a pinhead to as large as a grape and usually appear like a flat bump under the skin and sometimes yellow or orange colored. They usually don’t cause any pain with some minor irritation such as tenderness and itchy feeling.
There may be clusters of growths in the same area or several individual growths on different parts of the body. The exact causes of xanthoma is unknown, however, genetic factors have been indicated a cause of this conditions such as cogenosis type 1a, autosomal recessive hypercholesterolemia, alagille syndrome, and cholesterol storage disease.
Get Free Sample Copy at https://www.marketresearchfuture.com/sample_request/4860
The global xanthoma market is expected to reach USD 8.0 billion by 2023, and the market is projected to grow at a CAGR of ~ 6.0 % during the forecast period 2017-2023.
Some of the key players profiled in the report are
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Johnson & Johnson
- Bayer HealthCare Pharmaceuticals LLC
- Pfizer Inc.
- Novartis International AG
- Teva pharmaceutical industries
- Novo Nordisk
- Sanofi and others.
The global market has been segmented on the basis of types, diagnosis, treatment, and end user.
Based on the types, the market has been segmented as xanthelasma, xanthoma tuberosum, xanthoma tendinosum, eruptive xanthoma, xanthoma planum, palmar xanthoma, tuberoeruptive xanthoma, and others.
Based on the diagnosis, the market has been segmented as physical examination, biopsy, blood tests, and others.
Based on the treatment, the market has been segmented as drugs, surgery, chemical treatment, and others.
Based on the end user, the market has been segmented as hospitals and clinics, research and academics, and others.
The Americas accounts for a significant market share owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of dermatology procedures due to greater healthcare penetration in the U.S. and Canada drive the market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of dermatology procedures especially the xanthoma surgery treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also adding fuel the growth of the market in the US.
Europe is the second largest market in the world due to growing pharmaceutical industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large pharmaceutical industry.
Brows Complete Detailed Research Report at https://www.marketresearchfuture.com/reports/xanthoma-market-4860
Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to the fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of the healthcare industry in the Asia Pacific region is expected to drive the future market in the region.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt, and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub-Saharan Africa.
Table Of Contents
- REPORT PROLOGUE
- MARKET INTRODUCTION
2.2. Scope Of The Study
2.2.1. Research Objective
- RESEARCH METHODOLOGY
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
- MARKET DYNAMICS
- MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power Of Suppliers
5.1.2. Bargaining Power Of Buyers
5.1.3. Threat Of New Entrants
5.1.4. Threat Of Substitutes
5.1.5. Intensity Of Rivalry
5.2. Value Chain Analysis
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
Email: [email protected]